Gyala Therapeutics raised €3M in funding led by Invivo Partners, Nara Capital, and CDTI Innvierte. The funds will be used to expand operations and R&D efforts.
PRIVATESep 15, 2025
Amount Raised
€3 Million
Round Type
Funding Round
BarcelonaBiotechnologyHealth Care
Investors
CDTI InnvierteInvivo PartnersNara Capital
Description
Gyala Therapeutics, a Barcelona-based biotechnology company, raised €3M in funding. The company specializes in developing immunotherapies for hematological cancers. Backers included Invivo Partners, Nara Capital, and CDTI Innvierte. The funds will be used to expand operations and enhance R&D efforts.
Who to call at Gyala Therapeutics, and when
A new round usually means Gyala Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Gyala Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Gyala Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gyala Therapeutics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Gyala Therapeutics
Location
Barcelona, Catalonia, Spain
About
Gyala Therapeutics is a spin off from Hospital Clínic – IDIBAPS (Barcelona) focused on developing new CAR-T therapies for treating hematological malignancies. We raised raised around €8 million to date through equity investment from Invivo Partners, Nara Capital, and CDTI Innvierte, as well as non-dilutive funding from national innovation programs including NEOTEC and Public-Private Collaboration Projects.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gyala Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.